- Home
- NRDY vs HOWL Comparison
NRDY vs HOWL Comparison
Compare NRDY & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRDY
- HOWL
- Stock Information
- Founded
- NRDY 2007
- HOWL 2017
- Country
- NRDY United States
- HOWL United States
- Employees
- NRDY N/A
- HOWL N/A
- Industry
- NRDY Computer Software: Prepackaged Software
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- NRDY Technology
- HOWL Health Care
- Exchange
- NRDY Nasdaq
- HOWL Nasdaq
- Market Cap
- NRDY 121.6M
- HOWL 89.2M
- IPO Year
- NRDY N/A
- HOWL 2021
- Fundamental
- Price
- NRDY $0.95
- HOWL $2.02
- Analyst Decision
- NRDY Buy
- HOWL Strong Buy
- Analyst Count
- NRDY 8
- HOWL 3
- Target Price
- NRDY $3.46
- HOWL $12.00
- AVG Volume (30 Days)
- NRDY 4.5M
- HOWL 176.8K
- Earning Date
- NRDY 11-05-2024
- HOWL 08-08-2024
- Dividend Yield
- NRDY N/A
- HOWL N/A
- EPS Growth
- NRDY N/A
- HOWL N/A
- EPS
- NRDY N/A
- HOWL N/A
- Revenue
- NRDY $200,091,000.00
- HOWL $9,283,000.00
- Revenue This Year
- NRDY $4.56
- HOWL N/A
- Revenue Next Year
- NRDY $14.87
- HOWL $191.98
- P/E Ratio
- NRDY N/A
- HOWL N/A
- Revenue Growth
- NRDY 16.62
- HOWL N/A
- 52 Week Low
- NRDY $0.73
- HOWL $1.57
- 52 Week High
- NRDY $4.81
- HOWL $8.19
- Technical
- Relative Strength Index (RSI)
- NRDY 37.76
- HOWL 41.70
- Support Level
- NRDY $0.96
- HOWL $2.05
- Resistance Level
- NRDY $1.11
- HOWL $2.40
- Average True Range (ATR)
- NRDY 0.09
- HOWL 0.20
- MACD
- NRDY 0.02
- HOWL 0.00
- Stochastic Oscillator
- NRDY 21.11
- HOWL 13.92
About NRDY Nerdy Inc.
Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its purpose-built proprietary platform leverages technology, including AI, to connect learners of all ages to experts, delivering superior value on both sides of the network. Its comprehensive learning destination provides learning experiences across various subjects and multiple formats including one-on-one instruction, small group classes, large format group classes, and adaptive self-study.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.